Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease
Masayoshi Satō(Misawa City Hospital), Katsuya Inagaki(Otsuka (Japan)), Hiraku Hagita(Otsuka (Japan)), Daisuke Oka(Otsuka (Japan)), Isao Shibuya(Otsuka (Japan)), Makoto Matsumoto(Tottori University Hospital), Naomitsu Yamaya(Otsuka (Japan)), Kazuyuki Fujii(Otsuka (Japan)), H. Takagi(Tianjin University of Science and Technology)
Cited by 4
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k